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Abstract. Ideal bone graft must possess the desirable trait such as osteoconductive, osteoinductive 
and osteogenesis. Demineralized Bone Matrix (DBM) provides both osteoconductive and 
osteoinductive trait. Referring to the tissue engineering principle, the addition of mesenchymal stem 
cell would add the osteogenic trait to this procedure. The design of this study is experimental using 
Bovine DBM. Bone Marrow Mesenchymal Stem Cell (BMSCs) and Adipose Mesenchymal Stem 
Cells (ASCs) were taken from New Zealand white rabbit. There are two groups of treatment, 
divided into DBM implanted with BMSCs and DBM implanted with ASCs. Each BMSCs and 
ASCs groups is incubated in the normal and osteogenic culture plate. Evaluation is performed by 
counting the osteoblast and immunohistochemistry stain using Alkaline Phosphate and Osteocalcin. 
After 4 weeks of incubation, we found that the osteoblast count in BMSCs groups is higher 
compared to the ASCs groups in both culture condition (p<0.01) along with Alkaline Phosphate 
staining (p<0.05), while the Osteocalcin staining showed insignificant differences (p>0.05). This 
study revealed that xenogenic bovine DBM can act as the potential osteoinductive scaffold for the 
MSCs to differentiate. The tissue engineering application by combining MSCs and Bovine DBM 
can be considered as an alternative in managing bone defect cases. 
1. Introduction 
Bone defects are one of the major problems in orthopedic cases. It can occur in both trauma and 
non trauma cases. In bone defects, discontinuities of bone integrity can be caused by high-energy 
trauma, infection, tumor resection surgery, revision surgery, developmental deformities, and 
congenital malformation disorders. In this case, the size of the bone defect is too large and is 
included in the critically sized defect so it will not undergo spontaneous regeneration and require an 
interventional operation [1,2]. There are 500,000 surgeries that require bone grafting in the United 
States within a year with a total cost of 300 million USD in 1999 [3]. For comparison, the use of 
bone graft for orthopedic surgery at Dr. Soetomo General Hospital Surabaya has quadrupled from 
1997 to 2001 [4]. Bone defect treatment requires the bone graft to fill the gap and autologous bone 
graft is still a gold standard in the treatment of bone defect cases [5]. However, postoperative pain 
in bone donor source areas is of concern in the use of autologous bone graft besides its limitations 
of the bone sources [6]. Other alternatives for the graft subtitutes are allogenic bone graft and 
animals xenogenic bone graft. Allograft is physiologically more resembling the original bone and 
may have osteoinductive properties but the donor availability is also limited and disease 
transmission still be concerned. Whereas xenograft, owing to the abundance of donors, may be less 
expensive and more readily available even though its properties are limited to osteoconductive 
alone [7]. 
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With the rapid progress in the concept of tissue engineering, the use of stem cells that originally 
are exogenous cells in bone tissue engineering serves osteogenic capacity in stimulating bone 
healing [8,9]. Together with the development of scaffolding techniques by performing 
demineralization so cellular components that potentially induce immune response can be 
eliminated, thus providing potential scaffold as a microenvironment of the stem cell [8].  
Considering this, bovine Demineralized Bone Matrix (DBM) which is a xenogenic bone graft 
product can be rated as the alternative bone graft substitues, because its osteoconductive and 
osteoinductive properties can serve as a scaffold to support stem cell proliferation and 
differentiation thus provide osteogenic capacity [9]. Besides its economically cost, bovine DBM has 
been shown to have higher bone healing promotion capacities than the other type of bone graft and 
has lower immunogenicity and rejection reactions to surrounding tissue [10]. This current study will 
test and compare the ability of bovine DBM as scaffold and growth factor provider to stimulate 
differentiation of bone marrow and adipose mesenchymal stem cells to enhance its function as a 
bone graft. 
2. Materials and Methods 
This study was an in vitro laboratory study conducted at the Institute of Tropical Disease (ITD) 
Airlangga University and Tissue Bank of Dr. Soetomo General Hospital in Surabaya, Indonesia. 
The experimental unit was BMSCs and ASCs isolated from a healthy male New Zealand white 
rabbit 8 months old and weighing 3.0 kg approved by Airlangga University and Dr. Soetomo 
General Hospital research committee. In this study, bovine DBM added to isolated and replicated 
BMSCs and ASCs and divided into 4 groups (Figure 1). 
 
Figure 1. Research design 
2.1 Preparation of bovine demineralized bone matrix 
Demineralized bone matrix, prepared from the femoral condyle of the 2-year-old local cow, were 
collected from the local slaughterhouse. All bones were collected aseptically, and the soft tissues 
were removed before storage at -70°C. The bones were later cleared of fascia and cut into 1-cm 
pieces with a bone saw under saline (0.9% NaCl) solution lavage. Bone pieces were stored at -70°C 
until further use. The pieces were then thawed in 95% ethanol for 15 minutes and air dried. All 
bones were milled to  10 mm pieces. The pieces were then decalcified in 0.6 mol/l HCl at 4°C for 8 
days under constant agitation. After demineralization, all bone pieces were rinsed in sterile water 
and placed in phosphate buffer overnight. The bone pieces were then rinsed and the pH was 
adjusted to 7.3. They were placed in ethanol, the ethanol was allowed to evaporate overnight, and 
the pieces were packaged aseptically and stored at 4°C. 
2.2 Isolation of bone marrow mesenchymal stem cells 
Animals were anesthetized with ketamine (40 mg/kg, IM) and xylazine (5 mg/kg, IM). Isolation 
of MSCs from bone marrow performed aseptically by cleaning the skin of rabbit femur. The muscle 
and connective tissue were removed from the femur by scraping the diaphysis of the bone clean 
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then pulling the tissue toward the ends of the bone. A 27-gauge needle was inserted and flushed 
with Dulbecco’s Modified Eagle’s Medium (DMEM) and collect in a 15mL tube. The cell 
suspension was filtered through a 70-μm filter mesh. Bone marrow cells were cultured in 
DMEM+10% FBS+1% antibiotic-antimycotic solution tissue culture flask and incubated at 37°C 
with 5% CO2. For osteogenic culture, 10 mmol dexamethasone, 10 mmol β-glycerol-phosphate, 
0.05 mmol 2-phosphate ascorbic acid, 100 U/mL penicillin/streptomycin, and 10 mmol 1,25-
dihydroxy vitamin D3 were added to culture plate. 
2.3 Isolation of adipose mesenchymal stem cells 
Isolation of MSCs from adipose tissue was performed by subcutaneous fat pad liposuction under 
sterile conditions and washed with phosphate-buffered saline (PBS) containing 1% antibiotic-
antimycotic solution. The washing step was repeated until all blood vessels and connective tissues 
appeared to have been liberated. Adipose tissue then minced into small pieces and digested in 0.1% 
type 1 collagenase at 37°C with shaking for 2 hours and added 5mL DMEM containing 10% fetal 
bovine serum. For further disintegration of tissue aggregates, the sample was pipetted up and down 
several times. The cell suspension was filtered through 100 μm filter for the removal of the solid 
aggregates. The sample was subsequently centrifuged at 2000 rpm for 5 minutes at room 
temperature to complete the separation of the stromal cells from the adipocytes and the supernatant 
removed without disturbing the cells. The pellet was resuspended in 1 ml of lysis buffer to lyse red 
blood cells, incubated for 10 minutes, washed with 10 ml of PBS+1% antibiotic-antimycotic 
mixture and centrifuged at 2000 rpm for 5 minutes. The supernatant was removed and the cell pellet 
was resuspended in complete medium (DMEM with 20% fetal bovine serum (FBS) and 1% 
antibiotic-antimycotic solution) in a 25 cm2 culture flask and maintained in an incubator supplied 
with the humidified atmosphere of 5% CO2 at 37°C. 
2.4 Cell cultivation 
After one day, non-adherent cells were removed by two to three washes with PBS and adherent 
cells further cultured in complete medium. The medium was changed every 3 days until the 
monolayer of adherent cells reached 70-80% confluence. Cell passaging was performed using 
trypsin-EDTA solution 0.25%. Cell cultivation was performed up to the 3rd passage. 
2.5 Osteogenic differentiation 
Passage 3 MSCs were harvested by trypsin digestion as described above. The cells were counted 
and seeded at a density of 5×104 per well in a 9-well plate each group. The medium was changed 
twice per week for 2-3 weeks. The differentiation potential for osteogenesis was observed by the 
number of osteoblasts, alkaline phosphatase (ALP), and osteocalcin (OC). The number of 
osteoblasts assessed by hematoxylin-eosin staining, osteogenic marker gene of alkaline phosphatase 
and osteocalcin assessed by immunohistochemical staining under immunofluorescence microscopy. 
The Immunoreactive Score (IRS) by Remmele is a scale index is used to quantify the 
immunohistochemistry findings resulted by multiplication of immunoreactive cell percentage scores 
with color intensity scores on immunoreactive cells (Table 1). The data of each microscopic 
examinations were observed in 5 fields of view. 
Table 1. The semi-quantitative scale of the IRS (IRS result = AxB) 
A B 
Score 0:  no positive cells Score 0:  no color reactions 
Score 1:  positive cells less than 10% Score 1:  low color intensity 
Score 2:  positive cells ranging from 11% - 50% Score 2:  medium color intensity 
Score 3:  positive cells between from 51% - 80% Score 3:  strong color intensity 
Score 4:  positive cells between from more than 80%  
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3. Results and Discussion  
The MSCs cultures were observed by using an inverted light microscope. Adherence of spindle-
shaped cells to culture plastic flask was observed after 1 day of culture for both BMSCs and ASCs. 
Primary cultures reached 70-80% confluence faster in BMSCs than for ASCs (Figure 2). 
 
Figure 2. (A) Bone marrow stem cells culture, (B) Adipose stem cells culture 
Table 2 and Figure 3 reveal the mean total number of osteoblast cells in the BMSCs group 
added with bovine DBM and cultured at normal condition was 7.67±2.00 cells per 5 fields of view, 
higher than the osteoblast cell number in the ASCs group (1.44±1.24) and the difference is 
statistically significant (p = 0.000). Similiar significant result found for the mean of osteoblast 
number cells in the osteogenic culture,  BMSCs group was 120.67±28.54 compared to ASCs group 
73.00±42.32 cells number per 5 fields of view (p = 0.013).  
Table 2. Osteogenic differentiation of mesenchymal stem cells 
 BMSCs 
(Mean ± SD) 
ASCs 
(Mean ± SD) 
Culture Condition 
 Normal Osteogenic Normal Osteogenic 
Osteoblast Count (Cell number/ 5 FV) 7.67±2.00  120.67±28.54 1.44±1.24 73.00±42.32 
ALP Expression (IRS Score) 3.20±0.63  3.84±0.53 1.12±0.36 1.16±0.33 
Osteocalcin Expression (IRS Score) 1.96±0.59 3.16±0.45 2.18±0.75 3.29±0.61 
The average immunoreactive score (IRS) of ALP expression in BMSCs group added with bovine 
DBM within normal culture was 3.20±0.63 compared to 1.12±0.36 in ASCs groups and had a 
statistically significant effect (p = 0.000). Thus in osteogenic culture, the IRS mean of the ALP 
expression in the BMSCs group compared to ASCs group added with bovine DBM also differ 
significantly (p = 0,000). 
 
Figure 3. Number of osteoblast cell, immunoreactive score of ALP and osteocalcin for BMSCs and ASCs 
within normal and osteogenic culture, (*=p<0.05 **=p<0.01 *** p<0.001 #=p>0.05) 
*** 
# 
*** 
* 
*** 
# 
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The mean immunoreactive score of OC expression in the BMSCs group added with bovine 
DBM and cultured at normal condition was slightly lower than in the ASCs group (1.96±0.59 vs 
2.18±0.75) but not statistically significant (p = 0.498). Whereas the average IRS of osteocalcin 
expression at osteogenic culture in BMSCs group was 3.16±0.45 and 3.29±0.61 in ASCs group but 
the results were not statistically significant (p = 0.603). 
 
Figure 4. (A) HE staining on normal culture of BMSCs, (B) HE staining on normal culture of ASCs, (C) 
ALP expression in normal culture of BMSCs, (D) ALP expression in normal culture ASCs tissue, (E) OC 
expression in normal culture of BMSCs tissue, (F) OC expression result in normal culture ASCs tissue. 
 
Figure 5. (A) HE staining on osteogenic culture of BMSCs. (B) HE Staining on osteogenic culture of ASCs 
(C) ALP expression in osteogenic culture of BMSCs, (D) ALP expression in osteogenic culture ASCs tissue, 
(E) OC expression in osteogenic culture of BMSCs, (F) OC expression result in osteogenic culture ASCs. 
The use of stem cells in combination with scaffolds showed mixed results. The capability of 
mesenchymal stem cell differentiation (MSC) largely determines its use in managing various tissue 
damage. Stem cells derived from bone marrow are MSCs which was first studied and used widely. 
However, the morbidity induced when taking BMSCs causes other sources such as adipose and 
umbilical cord mesenchymal stem cells is further investigated [11]. Although most researchers 
conclude that BMSCs have better osteogenic proliferation capabilities than others [12-14], Kern et 
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al investigated the differentiation of bone marrow, adipose, and umbilical cord mesenchymal stem 
cells, became bone, and the results showed no significant difference between BMSCs and ASCs 
[15]. This led to the study using both types of stem cells growing at a rapid rate to handle 
orthopedic cases with bone defects. 
Studies by Garmie et al and Janicki et al showed promising results from stem cell and scaffold 
applications of non-connective fractures [16,17]. However, this study supported by several other 
studies, shows that BMSCs remain superior to muscle, adipose and umbilical cord [18-20]. Other 
studies have suggested the use of embryonic stem cells with scaffolds with promising results, but 
limited cell resources and difficulty in processing require further study to obtain optimal results 
[21]. Liu et al used ASCs inserted into the scaffold of the shells to correct the cranial defects in 
experimental animals with satisfactory results [22]. 
Several experiments have been conducted to combine DBM with MSC. Schubert et al reported a 
significant difference between the use of ASCs implanted into DBM compared with the autopsy of 
the cancellous bones in spinal fusion using pig experiments [23]. Evaluations performed using CT 
scans and histologic examinations showed better performance in the group DBM added A-MSCs. 
Several other researchers have tried to combine DBM with BMSCs with satisfactory results [24,25]. 
The results of this study indicate a significant comparison in which the amount of osteoblasts and 
alkaline phosphatase expression produced by differentiation of BMSCs is higher than ASCs, but the 
resulting osteocalcin expression did not differ significantly. This is in line with the previous 
hypothesis that BMSCs have a higher osteogenic differentiation potential than ASCs. This study 
also proves that bovine DBM is able to function as a scaffold where stem cells differentiate into 
osteoblasts. 
Studies using ASCs and the scaffold, both DBM and other scaffold forms, are still widely used 
to determine their efficacy in overcoming bone defects, as the use of BMSCs means increasing 
morbidity in patients in the form of pain in bone marrow collection sites. The authors argue that in 
vivo research is needed to directly compare the efficacy of DBM use in the treatment of bone 
defects in addition to ASCs or BMSCs. 
4. Conclusion  
Xenogenic bovine Demineralized Bone Matrix (DBM) is able to function as a scaffold where 
mesenchymal stem cells differentiate into osteoblast cells. Bone marrow mesenchymal stem cells 
have better osteogenic differentiation capabilities than adipose mesenchymal stem cells when 
implanted into Demineralized Bone Matrix. 
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